Learn More
Medchemexpress LLC 1-Hexadecanaminium, N-[2-[[(4-methoxyphenyl)methyl]-2-pyrimidinylamino]ethyl]dimethyl bromide | 553-08-2 | 99.9% | 5 MG

Supplier: Medchemexpress LLC HYB12465MG
Thonzonium bromide is an antibacterial and monocationic surface-active agent. It inhibits RANKL-induced osteoclast formation and bone resorption in vitro, preventing LPS-induced bone loss in vivo. It also inhibits proton transport in a dose-dependent manner, blocking the activation of NF-κB, ERK, and c-Fos, and the induction of NFATc1. This compound disrupts F-actin ring formation in mature osteoclasts, and has shown protective effects in a murine model of LPS-induced calvarial osteolysis.
- Antibacterial agent
- Monocationic surface-active agent
- Inhibits RANKL-induced osteoclast formation and bone resorption in vitro
- Prevents LPS-induced bone loss in vivo
- Inhibits proton transport
- Blocks RANKL-induced activation of NF-κB, ERK, and c-Fos
- Disrupts F-actin ring formation
- Activates human PXR in HepG2 cells
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.